评估泰国首次引入轮状病毒疫苗:从证据到政策
在泰国两个省份开展观察性研究,一省引入轮状病毒疫苗、另一省未提供疫苗,前瞻性队列随访儿童至18月龄并开展医院监测。结果显示,因轮状病毒腹泻住院的总体疫苗有效性为88%(95%CI 76-94),未接种疫苗地区未出现免疫的较大儿童住院减少40-69%,提示群体保护。
要点
- 因轮状病毒腹泻住院的总体疫苗有效性为88%(95%CI 76-94)。
- 在引入疫苗地区,连续两年轮状病毒住院的季节性高峰不再出现。
- 在疫苗项目引入前出生的未接种较大儿童中观察到群体保护,轮状病毒住院减少40-69%。
核心结论
- 轮状病毒疫苗在预防腹泻住院方面高度有效,并对未接种的较大儿童产生群体保护。
研究设计与样本
- 观察性研究,选择两个省份,一省引入轮状病毒疫苗、另一省未提供疫苗。
- 前瞻性队列研究纳入2月龄儿童并随访至18月龄,检测所有腹泻 episodes。
- 医院监测研究纳入所有5岁以下因腹泻住院的儿童,检测粪便样本中的轮状病毒。
- 利用两地未接种疫苗的较大儿童轮状病毒住院率数据判断免疫是否产生间接群体效应。
- 主要终点为基于轮状病毒腹泻住院的疫苗有效性(VE)和群体保护。
主要发现
- 队列研究中,因轮状病毒腹泻住院的总体VE为88%(95%CI 76-94)。
- 医院监测数据显示,连续两年在引入疫苗地区轮状病毒住院的季节性高峰不再出现。
- 在轮状病毒疫苗项目引入前出生的未接种较大儿童中观察到群体保护,轮状病毒住院减少40-69%。
关键数值与推荐
- 因轮状病毒腹泻住院的总体疫苗有效性为88%(95%CI 76-94)。
- 在引入疫苗地区,连续两年轮状病毒住院的季节性高峰不再出现。
- 在项目引入前出生的未接种较大儿童中,轮状病毒住院减少40-69%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We assessed the effectiveness and possible impact of introducing rotavirus vaccine into the routine immunization program. METHODS: Two provinces were selected for an observational study, one where vaccine was introduced and another where vaccine was not available. In these areas, two sub-studies were linked. The prospective cohort study enrolled children 2month old and followed them to the age of 18months to detect all diarrhea episodes. The hospital surveillance study enrolled all children up to age 5 hospitalized with diarrhea whose fecal samples were tested for rotavirus. Rates of rotavirus hospitalizations in older children who had not been vaccinated in both settings provided data to determine whether immunization had an indirect herd effect. The key endpoints for the study were both vaccine effectiveness (VE) based upon hospitalized rotavirus diarrhea and herd protection. FINDINGS: From the cohort study, the overall VE for hospitalized rotavirus diarrhea was 88% (95%CI 76-94). Data from hospital surveillance indicated that for 2 consecutive years, the seasonal peak of rotavirus admissions was no longer present in the vaccinated area. Herd protection was observed among older children born before the rotavirus vaccine program was introduced, who experienced a 40-69% reduction in admission for rotavirus. CONCLUSIONS: Rotavirus vaccine was highly effective in preventing diarrheal hospitalizations and in conferring herd protection among older children who had not been vaccinated.
引用
- Tharmaphornpilas P, Jiamsiri S, Boonchaiya S, et al. Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy. Vaccine. 2017. PMID: 28057385. doi:10.1016/j.vaccine.2016.12.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。